HOME >> MEDICINE >> NEWS
William Cohn, M.D., of Beth Israel Deaconess Medical Center, receives the 2000 Distinguished Inventor Award

BOSTON -- William Cohn, M.D., a cardiothoracic surgeon at Beth Israel Deaconess Medical Center, will receive the 2000 Distinguished Inventor Award from the Intellectual Property Owners Association (IPO). Cohn is being honored for inventing the Cohn Cardiac Stabilizer, a device and method that makes it possible to perform coronary artery bypass surgery on a beating heart without the use of a heart-lung machine. The award will be presented June 28 in the Caucus Room of the Russell Senate Office Building in Washington, D.C.

Traditionally, coronary artery bypass surgery involves stopping the heart and placing the patient on a heart-lung machine. Heart-lung machines circulate and filter the blood while adding oxygen and removing carbon dioxide. They can cause an inflammatory reaction that affects the entire body and can aggravate illnesses. The Cohn Cardiac Stabilizer is marketed by Genzyme Surgical Products as part of Genzyme-OPCAB Elite Stabilization System.

"Dr. Cohn is being recognized as one of America's most creative inventors," said Herbert C. Wamsley, executive director of IPO. "The heart surgery tool he invented advances the state of the art and will speed patient recovery and save lives."

Cohn, also an instructor in surgery at Harvard Medical School, performs approximately 200 open-heart surgeries a year. He received his medical degree and completed his residency program at Baylor College of Medicine, where he served under famed heart surgeon Michael Debakey. During the past two years, Cohn has licensed three additional patents for medical devices he has invented.

IPO is a trade association with programs to improve patent, copyright, trademark, and trade secret laws. IPO works to protect and improve the intellectual property systems that are vital to America's technological and economic leadership by bringing together the voices of large, medium and small businesses, independent inventors, authors and patent attorneys.

Beth Israel Deacone
'"/>

Contact: David Van Dam
dvandam@caregroup.harvard.edu
617-975-6135
Beth Israel Deaconess Medical Center
27-Jun-2000


Page: 1 2

Related medicine news :

1. National Academies News: William H. Foege to receive Public Welfare Medal, Academys highest honor
2. Peter H. Arger, MD, receives the 2004 AIUM William J. Fry Memorial Lecture Award
3. Fran Visco receives Frances Williams Preston Award from Vanderbilt University
4. Jeffrey S. Flier, M.D., elected to Institute of Medicine
5. UCSDs Victor Nizet, M.D., receives Pediatric Infectious Diseases Award
6. Statement from Claude Lenfant, M.D., NHLBI Director, on Trends in Hypertension
7. US cancer researchers launch first American-Israeli cancer conference
8. Unrestricted metabolic research grant awarded to Beth Israel Deaconess
9. Joslin and Beth Israel Deaconess Medical Center sign new joint venture clinical agreement
10. Beth Israel Deaconess Medical Center and Alveolus, Inc., announce agreement
11. Beth Israel Deaconess study documents outstanding surgical outcomes for diabetes patients

Post Your Comments:
(Date:5/25/2013)... California (PRWEB) May 25, 2013 According to ... titled “Hooked on a Feeling,” nearly 30 million Americans tan ... to tan despite knowing the health risks. ... seductive and even addictive effect on the brains of some ... included in the article so I can’t say that I ...
(Date:5/25/2013)... Newport Beach, California (PRWEB) May 25, 2013 ... weekend respectfully honoring those who have died serving our ... from work with prolonged partying and recklessness. The DUI ... Memorial Day Weekend DUI checklist to help keep this ... California’s Traffic Records System , there were more than ...
(Date:5/25/2013)... 25, 2013 Dr. Leslie Gerstman ... FDA-approved to lift skin on the neck, on the brow ... practice, Medical Aesthetics. , Ultherapy is a non-surgical procedure for ... healing process to lift the skin over time. The use ... to see and then treat the deepest support layers of ...
(Date:5/25/2013)... 25, 2013 Life science and analytical ... to detect and create a new substance with the ... are also known as biotechnology reagents. Such reagents are ... education. , This market is driven by factors such ... field of therapeutics, growth in research and rapid commercialization ...
(Date:5/25/2013)... Boise, Idaho (PRWEB) May 25, 2013 ... most prevalent type of peripheral neuropathy. According to neuropathy ... http://goo.gl/aLMtn , it is estimated that the disorder affects ... most common complication arising from Diabetes. The high blood ... of Diabetes and patients suffering from it usually tend ...
Breaking Medicine News(10 mins):Health News:Sun Damage – Are UV Rays Addictive? 2Health News:Criminal Attorneys Provide Memorial Day Weekend DUI Checklist and Safety Information 2Health News:Criminal Attorneys Provide Memorial Day Weekend DUI Checklist and Safety Information 3Health News:Dr. Leslie Gerstman Is Now Offering the Non-surgical Facelifting Procedure – Ultherapy – in NYC and NJ 2Health News:Life Sciences And Analytical Reagents Market - New Industry Research Report is Now Available for Pre-Order at Transparency Market Research 2Health News:Life Sciences And Analytical Reagents Market - New Industry Research Report is Now Available for Pre-Order at Transparency Market Research 3Health News:Diabetic Neuropathy treatment hits new grounds- Neuracel launches the complete natural treatment 2
(Date:5/23/2013)... , May 23, 2013  Hadasit Bio-Holdings Ltd. ... of biotech companies, based on intellectual property developed ... Israel ,s foremost medical research center, today ... Ltd., received significant funding from the Israeli Ministry ... Scientist (OCS) to support product development and advance ...
(Date:5/23/2013)... 2013 Anthem Blue Cross patients with HIV/AIDS ... them to obtain their medications by mail order under ... Kallas LLC.  The lawsuit, filed in ... Cross,s mandatory mail order program announced late last year ... "This settlement brings to a close a ...
(Date:5/23/2013)... Mass. , May 23, 2013  Hologic, ... HOLX ), a leading developer, manufacturer and supplier ... products, with an emphasis on serving the healthcare ... large-scale observational study in a U.S. clinical practice ... technology (breast tomosynthesis) with conventional 2D mammography alone ...
Breaking Medicine Technology:Hadasit Bio-Holdings Ltd. Portfolio Company - Cell Cure Neurosciences Ltd. Received Additional Government Support 2Blue Cross To Allow HIV/AIDS Patients to "Opt-Out" of Mandatory Mail-Order Rx Drug Program, Announces Consumer Watchdog 2Blue Cross To Allow HIV/AIDS Patients to "Opt-Out" of Mandatory Mail-Order Rx Drug Program, Announces Consumer Watchdog 3First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 2First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 3First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 4
Cached News: